Monday AM 1 Opening Session 2011 Mansfield Lecture ... - ISMRM

Poster Sessions
1 Physics & Astronomy, University of British Columbia, Vancouver, British Columbia, Canada; 2 Radiation Biology Unit, BC Cancer
Research Centre, Vancouver, British Columbia, Canada; 3 Pharmaceutical Sciences, University of British Columbia, Vancouver,
British Columbia, Canada
1686. Isostructural Re & 99m Tc Complexes of Gd-DTPA-Histidine for Dual-Modality MR/SPECT Imaging Agents
Ji-Ae Park 1 , Jung Young Kim 1 , Byoung Soo Kim 1 , Wonho Lee 1 , In Ok Ko 1 , Joo Hyun Kang 1 , Sang Moo Lim 2 , Hee-
Kyung Kim 3 , Yongmin Chang 3 , Tae-Jeong Kim 4 , Kyeong Min Kim 1
1 Molecular Imaging Research Center, Korea Institute of Radiological & Medical Science, Seoul, Nowon-Gu, Korea, Republic of;
2 Department of nuclear Medicine, Korea Institute of Radiological & Medical Science; 3 Department of Medical & Biological
Engineering, Kyungpook National University; 4 Department of Applied Chemistry, Kyungpook National University, Korea, Republic
of
1687. Heteroditopic Binding of MR Contrast Agents for Increased Relaxivity
Zhaoda Zhang 1 , Matthew Greenfield 2 , Andrew Kolodziej 2 , Peter Caravan 1
1 A. A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital & Harvard Medical School, Charlestown, MA,
United States; 2 Epix Pharmaceuticals, Lexington, MA, United States
1688. A New R 2/R 1 Ratiometric Method to Measure PH with a Dendrimer-Based PH-Responsive MRI Contrast Agent
Meser M. Ali 1 , Parvez Ismail Bhuiyan 1 , Hassan Bagher-Ebadian 2,3 , Branislava Janic 1 , Robert a knight 2,3 , James R.
Ewing 2,3 , Ali Syed Arbab 1
1 Radiology, Henry Ford Hospital, Detroit, MI, United States; 2 Neurology, Henry Ford Hospital; 3 Physics, Oakland University
1689. New Biodegradable Multimeric MPIO Contrast Agent Shows Rapid In Vitro & In Vivo Degradation & High
Sensitivity Contrast
Francisco Perez-Balderas 1,2 , Benjamin G. Davis 2 , Sander IvanKasteren 2 , Alexandr Khrapichev 1 , Andrew Jefferson 3 ,
Claire Bristow 1 , Sebastien Serres 1 , Robin P. Choudhury 3 , Daniel C. Anthony 4 , Nicola R. Sibson 1
1 CR/UK Gray Institute for Radiation Oncology & Biology, University of Oxford, Oxford, Oxfordshire, United Kingdom; 2 Chemistry
Research Laboratory, University of Oxford, Oxford, Oxfordshire, United Kingdom; 3 Department of Cardiovascular Medicine,
University of Oxford, Oxford, Oxfordshire, United Kingdom; 4 Department of Pharmacology, University of Oxford, Oxford,
Oxfordshire, United Kingdom
1690. Synthesis & Evaluation of PARACEST MRI Contrast Agents Containing an Amino Acid Arginine
Mojmir Suchy 1,2 , Alex X. Li 2 , Mark Milne 1 , Robert Bartha 2 , Robert H. E. Hudson 1
1 2
Chemistry, University of Western Ontario, London, Ontario, Canada; Robarts Research Institute, University of Western Ontario,
London, Ontario, Canada
1691. A Novel Gadolinium-Based Contrast Agent Targeted to Cathepsin-D
Robert Ta 1,2 , Alex X Li 1 , Mojmir Suchy 3 , Robert H. E. Hudson 3 , Stephen Pasternak 4,5 , Robert Bartha 1,2
1 Imaging Research Laboratories, Robarts Research Institute, London, Ontario, Canada; 2 Medical Biophysics, the University of
Western Ontario, London, Ontario, Canada; 3 Chemistry, the University of Western Ontario, London, Ontario, Canada; 4 Molecular
Brain Research Group, Robarts Research Institute, London, Ontario, Canada; 5 Clinical Neurological Sciences, the University of
Western Ontario, London, Ontario, Canada
1692. Gd-Albumin Relaxivity in the Rat Thalamus In Vivo at 11.1 T
Garrett William Astary 1 , Svetlana Kantorovich 2 , Paul Richard Carney 1,3 , Malisa Sarntinoranont 4 , Thomas Harold
Mareci 5
1 Biomedical Engineering, University of Florida, Gainesville, FL, United States; 2 Neuroscience, University of Florida; 3 Division of
Pediatric Neurology, University of Florida; 4 Mechanical & Aerospace Engineering, University of Florida; 5 Biochemistry & Molecular
Biology, University of Florida
1693. Efficacy of Different Lipid-Coated Nanoclusters of Iron Oxide for Image-Based Detection of Labeled Cells
Geralda A. F. van Tilborg 1 , David P. Cormode 2 , Peter A. Jarzyna 2 , Annette van Der Toorn 1 , Susanne M. A. van Der
Pol 3 , Louis van Bloois 4 , Gert Storm 4 , Willem J. M. Mulder 2 , Helga E. de Vries 3 , Rick M. Dijkhuizen 1
1 Image Sciences Institute, University Medical Center Utrecht, Utrecht, Netherlands; 2 Translational & Molecular Imaging Institute,
Mount Sinai School of Medicine, New York, United States; 3 3Department of Molecular Cell Biology & Immunology, VU University
Medical Center, Amsterdam, Netherlands; 4 Department of Pharmaceutics, Institute for Pharmaceutical Sciences, Utrecht, Netherlands
1694. Copper Nanoparticles for T1-Weighted MR Molecular Imaging
Shelton D. Caruthers 1 , Dipanjan Pan 1 , Angana Senpan 1 , Anne H. Schmieder 1 , Patrick J. Gaffney 2 , Samuel A.
Wickline 1 , Gregory M. Lanza 1
1 2
C-TRAIN, Washington University School of Medicine, St. Louis, MO, United States; Dept. of Surgery, St. Thomas' Hospital,
London, United Kingdom
1695. Multi-Modality PET-MR Perfluorocarbon Nanoparticle Contrast Agent for Ligand-Targeted Quantitative
Imaging
Shelton D. Caruthers 1 , Monica Shokeen 2 , Ricardo Ferdani 2 , Hua Pan 1 , Samuel A. Wickline 1 , Carolyn J. Anderson 2
195